Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Chromatin Immunoprecipitation [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA004122 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA004122, RRID:AB_2667139
- Product name
- Anti-CTCF
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human CTCF, Gene description: CCCTC-binding factor (zinc finger protein), Validated applications: IHC, ICC, ChIP, Uniprot ID: P49711, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.05 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Divergent transcriptional regulation of astrocyte reactivity across disorders
Expression of CCCTC‐binding factor (CTCF) is linked to poor prognosis in prostate cancer
Burda J, O’Shea T, Ao Y, Suresh K, Wang S, Bernstein A, Chandra A, Deverasetty S, Kawaguchi R, Kim J, McCallum S, Rogers A, Wahane S, Sofroniew M
Nature 2022;606(7914):557-564
Nature 2022;606(7914):557-564
Expression of CCCTC‐binding factor (CTCF) is linked to poor prognosis in prostate cancer
Höflmayer D, Steinhoff A, Hube‐Magg C, Kluth M, Simon R, Burandt E, Tsourlakis M, Minner S, Sauter G, Büscheck F, Wilczak W, Steurer S, Huland H, Graefen M, Haese A, Heinzer H, Schlomm T, Jacobsen F, Hinsch A, Poos A, Oswald M, Rippe K, König R, Schroeder C
Molecular Oncology 2019;14(1):129-138
Molecular Oncology 2019;14(1):129-138
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Main image
- Experimental details
- ChIP-Exo-Seq composite graph for Anti-CTCF (HPA004122, Lot A96611) tested in K562 cells. Strand-specific reads (blue: forward, red: reverse) and IgG controls (black: forward, grey: reverse) are plotted against the distance from a composite set of reference binding sites. The antibody exhibits robust target enrichment compared to a non-specific IgG control and precisely reveals its structural organization around the binding site. Data generated by Prof. B. F. Pugh´s Lab at Cornell University.